Inflammatory Bowel Diseases Clinical Trials

114 recruitingLast updated: June 17, 2026

There are 114 actively recruiting inflammatory bowel diseases clinical trials across 54 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include London, United Kingdom, New York, New York, United States, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


Inflammatory Bowel Diseases Trials at a Glance

114 actively recruiting trials for inflammatory bowel diseases are listed on ClinicalTrialsFinder across 6 cities in 54 countries. The largest study group is Not Applicable with 31 trials, with the heaviest enrollment activity in London, New York, and Shanghai. Lead sponsors running inflammatory bowel diseases studies include Massachusetts General Hospital, Tanta University, and University of Michigan.

Browse inflammatory bowel diseases trials by phase

Treatments under study

About Inflammatory Bowel Diseases Clinical Trials

Looking for clinical trials for Inflammatory Bowel Diseases? There are currently 110 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Bowel Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Bowel Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 114 trials

Recruiting
Not Applicable

BOOM-IBD2 Pivotal Clinical Trial

Inflammatory Bowel DiseasesUlcerative Colitis
Boomerang Medical137 enrolled19 locationsNCT06571669
Recruiting

A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea

Inflammatory Bowel Diseases
Janssen Korea, Ltd., Korea8,000 enrolled1 locationNCT07520747
Recruiting
Phase 2

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

ColitisInflammatory Bowel DiseasesUlcerative Colitis+1 more
Spyre Therapeutics, Inc.645 enrolled223 locationsNCT07012395
Recruiting
Phase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled226 locationsNCT06226883
Recruiting
Phase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Inflammatory Bowel DiseasesCrohn's DiseaseUlcerative Colitis+1 more
Eli Lilly and Company150 enrolled67 locationsNCT04844606
Recruiting
Phase 1

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Inflammatory Bowel DiseasesUlcerative ColitisClostridioides Difficile Infection
University of Alberta85 enrolled2 locationsNCT07401680
Recruiting

Mechanism of Chronic Pain in Patients With IBD

Inflammatory Bowel Diseases
Queen Mary University of London25,600 enrolled1 locationNCT04995224
Recruiting
Phase 1

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.135 enrolled30 locationsNCT06754891
Recruiting
Phase 2

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
University of Birmingham58 enrolled5 locationsNCT06286709
Recruiting
Not Applicable

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
University of Michigan68 enrolled1 locationNCT06094608
Recruiting

Predictors of Prognosis in IBD Patients

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Seoul National University Bundang Hospital100 enrolled1 locationNCT05653011
Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting

Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study

Inflammatory Bowel Diseases
Nanfang Hospital, Southern Medical University420 enrolled1 locationNCT07539727
Recruiting

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis, Pediatric
University of North Carolina, Chapel Hill1,100 enrolled4 locationsNCT07198113
Recruiting
Phase 2

Pentoxifylline in Patients With Ulcerative Colitis

Inflammatory Bowel Diseases
Ihab Elsayed Hassan60 enrolled1 locationNCT07349472
Recruiting
Not Applicable

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

Inflammatory Bowel DiseasesCrohn's Disease Relapse
Shanghai Institute of Acupuncture, Moxibustion and Meridian106 enrolled1 locationNCT06553053
Recruiting

Therapeutic Endpoint in Pediatric IBD Conditions

Inflammatory Bowel DiseasesCrohn DiseaseColitis Ulcerative
Children's National Research Institute60 enrolled1 locationNCT06065228
Recruiting
Not Applicable

Heart Rate Variability and Inflammatory Bowel Disease

Inflammatory Bowel Diseases
Emory University128 enrolled3 locationsNCT06537258
Recruiting

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

Inflammatory Bowel DiseasesSclerodermaVasculitis+2 more
University Hospital, Toulouse3,000 enrolled1 locationNCT05251415
Recruiting
Phase 2Phase 3

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

Inflammatory Bowel Diseases
Mostafa Bahaa50 enrolled1 locationNCT05986136